2m 2m 2m 2m 2m 2m 2m
Medicine Mn T (SHWZ)
OTC
$0.000001$0.00 (0.00%)
Price as of May 22, 2026- $80.00Market Cap
- -99.99%1-Year Change
- Pharmaceutical RetailersIndustry
Medicine Mn T (SHWZ)
$0.000001$0.00 (0.00%)
Annual
Quarterly
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 172.4M +8.23% | 159.3M +46.97% | 108.4M +351.73% | 24.0M N/A | |
Cost of Revenue | 96.4M +29.69% | 74.3M +25.87% | 59.1M +242.88% | 17.2M N/A | |
Gross Profit | 76.0M -10.59% | 85.0M +72.29% | 49.4M +628.54% | 6.8M N/A | |
Sales and Marketing Expense | 39.9M +35.78% | 29.4M +76.92% | 16.6M +267.32% | 4.5M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 20.9M +90.09% | 11.0M +28.40% | 8.6M +1,699.62% | 476,592 N/A | |
Total Operating Expenses | 72.7M +0.78% | 72.2M +85.33% | 38.9M +31.23% | 29.7M N/A | |
Operating Profit | 3.3M -74.42% | 12.9M +23.50% | 10.4M +145.45% | -22.9M N/A | |
Interest Income | 1,816 +104.62% | -39,270 -118.12% | 216,771 N/A | N/A N/A | |
Interest Expense | -32.1M +6.40% | -30.1M +329.69% | -7.0M +16,818.18% | -41,460 N/A | |
Interest Income and Expense and Net | -32.1M +6.26% | -30.2M +343.97% | -6.8M +16,295.34% | -41,460 N/A | |
Total Nonoperating Income and Expense | -18.1M +10.19% | -16.4M -293.09% | 8.5M +228.79% | 2.6M N/A | |
Income before Taxes | -14.8M +314.86% | -3.6M -149.76% | 7.2M +135.31% | -20.3M N/A | |
Income Taxes | 19.7M +32.50% | 14.9M +238.89% | 4.4M +588.95% | -899,109 N/A | |
Extraordinary Items | 1.8M -77.51% | 8.0M N/A | N/A N/A | N/A N/A | |
Net Income | -34.5M +87.08% | -18.5M -227.20% | 14.5M +174.78% | -19.4M N/A | |
Net Income from Continuing Operations Applicable to Common | -42.7M +62.56% | -26.3M -466.24% | 7.2M +135.31% | -20.3M N/A | |
Basic EPS and Net Income | -0.66 +34.69% | -0.49 -388.24% | 0.17 +136.17% | -0.47 N/A | |
Diluted EPS and Net Income | -0.66 +34.69% | -0.49 +716.67% | -0.06 -87.23% | -0.47 N/A | |
Basic Weighted Average Shares | 64.5M +20.32% | 53.6M -47.09% | 101.4M +145.94% | 41.2M N/A | |
Diluted Weighted Average Shares | 64.5M +20.32% | 53.6M -47.09% | 101.4M +145.94% | 41.2M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 19.2M -50.58% | 38.9M -63.39% | 106.4M +8,541.75% | 1.2M N/A | |
Short-Term Investments | 456,099 +0.40% | 454,283 N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 19.7M -49.99% | 39.4M -62.97% | 106.4M +8,541.75% | 1.2M N/A | |
Total Current Assets | 53.7M -25.19% | 71.7M -42.11% | 123.9M +1,966.11% | 6.0M N/A | |
Accumulated Depreciation | 8.7M +78.40% | 4.9M +146.36% | 2.0M +127.94% | 872,579 N/A | |
Property and Plant and Equipment and Net | 31.1M +14.86% | 27.1M +164.20% | 10.3M +296.67% | 2.6M N/A | |
Total Long-Term Assets | 304.5M +21.23% | 251.1M +55.88% | 161.1M +149.08% | 64.7M N/A | |
Total Assets | 358.1M +10.92% | 322.9M +13.28% | 285.0M +303.25% | 70.7M N/A | |
Income Taxes Payable | 25.7M +229.94% | 7.8M +284.66% | 2.0M N/A | N/A N/A | |
Total Short-Term Debt | 3.5M +48.75% | 2.4M +1,672.89% | 134,498 -97.31% | 5.0M N/A | |
Total Current Liabilities | 55.5M +17.04% | 47.4M +4.68% | 45.3M +266.20% | 12.4M N/A | |
Total Long-Term Debt | 153.3M +22.10% | 125.5M +28.76% | 97.5M +601.22% | 13.9M N/A | |
Total Long-Term Liabilities | 183.4M +27.95% | 143.3M +34.97% | 106.2M +541.78% | 16.5M N/A | |
Total Liabilities | 238.9M +25.24% | 190.7M +25.92% | 151.5M +423.95% | 28.9M N/A | |
Retained Earnings | -80.8M +74.71% | -46.2M +66.49% | -27.8M -34.33% | -42.3M N/A | |
Total Stockholders Equity | 119.3M -9.74% | 132.2M -1.05% | 133.6M +219.74% | 41.8M N/A | |
Total Shares Outstanding | 74.0M +33.97% | 55.2M +23.47% | 44.7M +6.04% | 42.2M N/A | |
Cash Flow | |||||
Cash from Operating Activities | 12.2M +7.44% | 11.4M -80.19% | 57.3M +685.06% | -9.8M N/A | |
Capital Expenditures | 7.9M -46.90% | 14.8M +162.73% | 5.6M N/A | N/A N/A | |
Cash from Investing Activities | -26.4M -66.61% | -79.2M -2.44% | -81.2M +144.33% | -33.2M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -5.5M -1,549.53% | 376,895 -99.71% | 129.0M +304.36% | 31.9M N/A | |
Financials Ratio | |||||
Gross Margin | 44.09% -17.35% | 53.34% +17.18% | 45.52% +61.28% | 28.23% N/A | |
Operating Margin | 1.91% -76.36% | 8.07% -15.97% | 9.60% +110.06% | -95.43% N/A | |
Return on Assets | -10.15% +67.00% | -6.08% -174.43% | 8.16% +121.63% | -37.73% N/A | |
Return on Equity | -27.48% +97.70% | -13.90% -183.93% | 16.56% +129.15% | -56.81% N/A | |
Revenue Growth | 8.23% -82.48% | 46.97% -86.65% | 351.74% +276.02% | 93.54% N/A | |
Current Ratio | 0.97 -36.08% | 1.51 -44.70% | 2.74 +464.22% | 0.49 N/A | |
Cash Ratio | 0.35 -57.77% | 0.82 -65.03% | 2.35 +2,260.14% | 0.10 N/A | |
Debt-to-Equity Ratio | 1.31 +35.82% | 0.97 +32.43% | 0.73 +61.50% | 0.45 N/A | |
Debt-to-Assets Ratio | 0.44 +10.53% | 0.40 +15.65% | 0.34 +28.09% | 0.27 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow